| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC2968 |
| Trial ID | NCT05290155 |
| Disease | Peripheral T-Cell Lymphoma | Anaplastic Large Cell Lymphoma | T-Cell Acute Lymphoblastic Leukemia | Angioimmunoblastic T-Cell Lymphoma |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Anti-CD7 CAR-T Cell Therapy for Relapse and Refractory CD7 Positive T Cell Malignancies |
| Year | 2022 |
| Country | China |
| Company sponsor | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
| Other ID(s) | SHYSXY-202105-CD7-CART |
| Cohort 1 | |||||||||
|
|||||||||